Literature DB >> 23100563

Attenuation of biopterin synthesis prevents Escherichia coli K1 invasion of brain endothelial cells and the development of meningitis in newborn mice.

Muthusamy V Shanmuganathan1, Subramanian Krishnan, Xiaowei Fu, Nemani V Prasadarao.   

Abstract

Elevated levels of pterins and nitric oxide (NO) are observed in patients with septic shock and bacterial meningitis. We demonstrate that Escherichia coli K1 infection of human brain microvascular endothelial cells (HBMECs) induces the expression of guanosine triphosphate cyclohydrolase (GCH1), the rate-limiting enzyme in pterin synthesis, thereby elevating levels of biopterin. DAHP (2,4-diamino hydroxyl pyrimidine), a specific inhibitor of GCH1, prevented biopterin and NO production and invasion of E. coli K1 in HBMECs. GCH1 interaction with Ecgp96, the receptor for outer membrane protein A of E. coli K1, also increases on infection, and suppression of Ecgp96 expression prevents GCH1 activation and biopterin synthesis. Pretreatment of newborn mice with DAHP prevented the production of biopterin and the development of meningitis. These results suggest a novel role for biopterin synthesis in the pathogenesis of E. coli K1 meningitis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23100563      PMCID: PMC3523800          DOI: 10.1093/infdis/jis656

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  36 in total

1.  GTP cyclohydrolase I is coinduced in hepatocytes stimulated to produce nitric oxide.

Authors:  D A Geller; M Di Silvio; T R Billiar; K Hatakeyama
Journal:  Biochem Biophys Res Commun       Date:  2000-09-24       Impact factor: 3.575

Review 2.  Chaperone-mediated protein folding.

Authors:  A L Fink
Journal:  Physiol Rev       Date:  1999-04       Impact factor: 37.312

Review 3.  Nitric oxide synthase inhibition in sepsis? Lessons learned from large-animal studies.

Authors:  Balázs Hauser; Hendrik Bracht; Martin Matejovic; Peter Radermacher; Balasubramanian Venkatesh
Journal:  Anesth Analg       Date:  2005-08       Impact factor: 5.108

4.  Phosphoinositide 3-kinase in nitric oxide synthesis in macrophage: critical dimerization of inducible nitric-oxide synthase.

Authors:  Kouhei Sakai; Harumi Suzuki; Hiroyo Oda; Takaaki Akaike; Yoshinao Azuma; Tomoyuki Murakami; Kazuro Sugi; Takehito Ito; Hiroshi Ichinose; Shigeo Koyasu; Mutsunori Shirai
Journal:  J Biol Chem       Date:  2006-04-24       Impact factor: 5.157

Review 5.  Nitric oxide synthases: structure, function and inhibition.

Authors:  W K Alderton; C E Cooper; R G Knowles
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

6.  GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence.

Authors:  Irmgard Tegeder; Michael Costigan; Robert S Griffin; Andrea Abele; Inna Belfer; Helmut Schmidt; Corina Ehnert; Jemiel Nejim; Claudiu Marian; Joachim Scholz; Tianxia Wu; Andrew Allchorne; Luda Diatchenko; Alexander M Binshtok; David Goldman; Jan Adolph; Swetha Sama; Steven J Atlas; William A Carlezon; Aram Parsegian; Jörn Lötsch; Roger B Fillingim; William Maixner; Gerd Geisslinger; Mitchell B Max; Clifford J Woolf
Journal:  Nat Med       Date:  2006-10-22       Impact factor: 53.440

7.  A yeast 2-hybrid analysis of human GTP cyclohydrolase I protein interactions.

Authors:  Lance Swick; Gregory Kapatos
Journal:  J Neurochem       Date:  2006-06       Impact factor: 5.372

8.  Induced nitric oxide inhibits IL-6-induced stat3 activation and type II acute phase mRNA expression.

Authors:  R T Villavicencio; S Liu; M R Kibbe; D L Williams; R W Ganster; K F Dyer; D J Tweardy; T R Billiar; B R Pitt
Journal:  Shock       Date:  2000-06       Impact factor: 3.454

Review 9.  Tetrahydrobiopterin biosynthesis, regeneration and functions.

Authors:  B Thöny; G Auerbach; N Blau
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

10.  The novel nitric oxide synthase inhibitor 4-amino-tetrahydro-L-biopterine prevents brain edema formation and intracranial hypertension following traumatic brain injury in mice.

Authors:  Nicole A Terpolilli; Klaus Zweckberger; Raimund Trabold; Lothar Schilling; Reinhard Schinzel; Frank Tegtmeier; Nikolaus Plesnila
Journal:  J Neurotrauma       Date:  2009-11       Impact factor: 5.269

View more
  6 in total

1.  Angiotensin II receptor type 1--a novel target for preventing neonatal meningitis in mice by Escherichia coli K1.

Authors:  Subramanian Krishnan; Muthusamy V Shanmuganathan; Douglas Behenna; Brian M Stoltz; Nemani V Prasadarao
Journal:  J Infect Dis       Date:  2013-09-16       Impact factor: 5.226

2.  Escherichia coli K1 induces pterin production for enhanced expression of Fcγ receptor I to invade RAW 264.7 macrophages.

Authors:  Muthusamy V Shanmuganathan; Subramanian Krishnan; Xiaowei Fu; Nemani V Prasadarao
Journal:  Microbes Infect       Date:  2013-10-23       Impact factor: 2.700

3.  Rational Design and Evaluation of an Artificial Escherichia coli K1 Protein Vaccine Candidate Based on the Structure of OmpA.

Authors:  Hao Gu; Yaling Liao; Jin Zhang; Ying Wang; Zhiyong Liu; Ping Cheng; Xingyong Wang; Quanming Zou; Jiang Gu
Journal:  Front Cell Infect Microbiol       Date:  2018-05-23       Impact factor: 5.293

Review 4.  Host-pathogen interactions in bacterial meningitis.

Authors:  Kelly S Doran; Marcus Fulde; Nina Gratz; Brandon J Kim; Roland Nau; Nemani Prasadarao; Alexandra Schubert-Unkmeir; Elaine I Tuomanen; Peter Valentin-Weigand
Journal:  Acta Neuropathol       Date:  2016-01-07       Impact factor: 17.088

Review 5.  Virulence Factors of Meningitis-Causing Bacteria: Enabling Brain Entry across the Blood-Brain Barrier.

Authors:  Rosanna Herold; Horst Schroten; Christian Schwerk
Journal:  Int J Mol Sci       Date:  2019-10-29       Impact factor: 5.923

Review 6.  The Potentials of Melatonin in the Prevention and Treatment of Bacterial Meningitis Disease.

Authors:  Dong Zhang; Shu Xu; Yiting Wang; Guoqiang Zhu
Journal:  Molecules       Date:  2021-03-05       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.